Analysis

Will NZD see deeper correction as European fx outperform?

Currencies and equities traded higher on the back of better than expected economic data and reports from Russia that they’ve won the global vaccine race. While Russia announced the world’s first approved vaccine it has not finished phase 3 trials which the World Health Organization deems essential for statistical accuracy. There are currently 8 other vaccines in phase 3 trials from the US, US/UK, Germany and China.  Nonetheless, pharmaceutical companies are getting close and the single most important game changer for the global economy could be right around the corner. The persistent gains in stocks reflects the market’s optimism and their hope that  medical advances made over the past few months puts the worst behind us. 

Although the US dollar ended the day lower against all of the major currencies except for the Japanese Yen most of those losses occurred during the Asian and European hours. During the NY session, dollar bulls were in control. Stronger than expected producer prices helped along with an uptick in Redbook retail sales ahead of Friday’s consumer spending report. Yet bonds were the primary driver of dollar gains. Ten year Treasury yields saw their single biggest one day rise in more than 2 months as the S&P 500 headed for a test of its record high.

Euro continues to be one of the strongest currencies. Despite signs of a double top and its struggle to close above 1.08, the pair still managed to outperform most of its peers. The expectations component of the German ZEW survey also rose to its highest level since 2003. Investors were less confident about current conditions but very optimistic about where the economy is headed which is testament to the local government and EU’s efforts. Industrial production numbers from the Eurozone are scheduled for release tomorrow and the outcome is expected to be better as well. Although EUR/USD remains at risk of a double top correction, the single currency could continue to outperform its peers. 

Sterling also traded higher but mixed labor market numbers held the currency back. Even though the unemployment rate improved, claimant count increased much more than expected in July and average hourly earnings fell. The only reason why the jobless rate improved was because unemployed workers are discouraged from looking for new work. Tomorrow’s second quarter GDP numbers also poses a risk for sterling. Although spending and trade improved towards the end of the quarter, Q2 was a tough one for many countries and the UK is no exception.

The focus shifts to New Zealand tonight with a Reserve Bank’s monetary policy announcement on the calendar. New Zealand was one of the first countries to defeat COVID, reporting 100 days without community transmission. Unfortunately just 24 hours, they reported their first outbreak with four members of one family testing positive for COVID19, prompting the government to put its largest city into lockdown. Auckland was placed on level 3 lockdown for the next 3 days which involves closures of restaurants, bars, schools and nurseries. Travel out of the city will also be restricted as Prime Minister Arden orders stay at home measures. The rest of the country will go to level 2 with mass gatherings limited to 100 people and physical distancing of 2 meters in public areas. The New Zealand dollar extended its losses on the back of these latest developments as investors wonder how this will affect the RBNZ’s views. 

Recent data also shows New Zealand’s recovery losing momentum. According to the table below, since the last policy meeting in June, consumer and business sentiment weakened as spending softened. Home sales are growing but building permits and house prices are relatively stagnant and inflationary measures are mixed. So while the central bank has no reason question the direction of the economy, these reports could curtail their optimism.  As for the Australian dollar, it shrugged off weaker business confidence as the Canadian dollar rallied on the back of stronger housing starts. 

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.